Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development-Reference-Cited by-同舟云学术

Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development

Published:2020-11 Issue:11 Volume:61 Page:2365-2385
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Bialer Meir¹^ORCID,Johannessen Svein I.²³^ORCID,Koepp Matthias J.⁴^ORCID,Levy René H.⁵^ORCID,Perucca Emilio⁶⁷^ORCID,Perucca Piero⁸⁹¹⁰^ORCID,Tomson Torbjörn¹¹^ORCID,White H. Steve¹²^ORCID

Affiliation:

1. Faculty of Medicine School of Pharmacy and David R. Bloom Center for Pharmacy Institute for Drug Research Hebrew University of Jerusalem Jerusalem Israel

2. National Center for Epilepsy Sandvika Norway

3. Department of Pharmacology Oslo University Hospital Oslo Norway

4. Department of Clinical and Experimental Epilepsy UCL Institute of Neurology London UK

5. Department of Pharmaceutics and Neurological Surgery University of Washington Seattle WA USA

6. Department of Internal Medicine and Therapeutics University of Pavia Pavia Italy

7. IRCCS Mondino Foundation Pavia Italy

8. Department of Neuroscience Central Clinical School Monash University Melbourne Victoria Australia

9. Department of Medicine and Neurology Royal Melbourne Hospital University of Melbourne Melbourne Victoria Australia

10. Department of Neurology Alfred Health Melbourne Victoria Australia

11. Department of Clinical Neuroscience Karolinska Institute Stockholm Sweden

12. Department of Pharmacy School of Pharmacy University of Washington Seattle WA USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.16726

Reference60 articles.

1. Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development

2. Sobi (Swedish Orphan Biovitrum).Kineret. Summary of product characteristics (last revision March 14 2019). Available at:https://www.medicines.org.uk/emc/product/559/smpc. Accessed 2020 February 18 2020.

3. Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development

4. Functional deficiency in endogenous interleukin‐1 receptor antagonist in patients with febrile infection‐related epilepsy syndrome

5. Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis;Expert Opinion on Drug Discovery;2024-07-29

2. Established and emerging GABAA receptor pharmacotherapy for epilepsy;Frontiers in Pharmacology;2024-02-21

3. Research Status, Synthesis and Clinical Application of Antiepileptic Drugs;Current Medicinal Chemistry;2024-02

4. Intravenous Ganaxolone: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability in Healthy Adults;Clinical Pharmacology in Drug Development;2024-01-17

5. Interneuron Transplantation for Drug-Resistant Epilepsy;Neurosurgery Clinics of North America;2024-01